☆ 4.5 Article

A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics

BLOOD CANCER JOURNAL (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study

Ilja Kalashnikov et al.

Summary: Marginal zone lymphoma (MZL) is a slow-growing B-cell malignancy, but some patients may undergo transformation to aggressive large B-cell lymphoma. In this population-based study in Finland, the transformation rate of MZL was 4.7% at 10 years, with the highest incidence observed in splenic MZL patients. Transformation was associated with a significantly increased risk of death. The 10-year relative survival rate for MZL patients was 79%, with a reduction in excess mortality in recent years.

BLOOD CANCER JOURNAL (2023)

Add to Collection

Review Hematology

Marginal zone lymphoma: present status and future perspectives

Chan Y. Cheah et al.

HAEMATOLOGICA (2022)

Add to Collection

Article Hematology

Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation

Gabriela Bastidas-Mora et al.

Summary: The study describes 36 patients with splenic marginal zone lymphoma (SMZL) with transformation, with predictors including cytopenias, hypoalbuminaemia, and complex karyotype. Patients with SMZL-T have a higher risk of death, mostly developing diffuse large B-cell lymphoma post transformation, with predictors for worse survival being high-risk International Prognostic Index and lack of complete response.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Add to Collection

Review Oncology

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Rita Alaggio et al.

Summary: This article provides an overview of the upcoming 5th edition of the World Health Organization classification of lymphoid tumors, highlighting changes from the previous edition such as reorganization of entities, modification of nomenclature, revision of diagnostic criteria, deletion of entities, introduction of new entities, and inclusion of tumor-like lesions.

LEUKEMIA (2022)

Add to Collection

Article Oncology

Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers

Catarina Dantas Rodrigues et al.

Summary: The treatment of Splenic and Nodal Marginal Zone Lymphoma is still not standardized, with uncertain outcomes for histologic transformation. Prospective trials are needed to establish a standard treatment protocol. Age has been confirmed as a prognostic factor, emphasizing the importance of personalized treatment strategies.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)

Add to Collection

Article Hematology

Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study

Mirian Brink et al.

Summary: The study investigated whether overall survival (OS) of patients with DLBCL receiving R-biosimilars is similar to patients treated with R-originator. Results showed that the 3-year OS did not differ between patients treated with R-originator or R-biosimilars, supporting the use of R-biosimilars in DLBCL treatment management.

BLOOD ADVANCES (2021)

Add to Collection

Review Oncology

Marginal Zone Lymphoma: State-of-the-Art Treatment

Ariel Sindel et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)

Add to Collection

Article Hematology

Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation

Juan Pablo Alderuccio et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Add to Collection

Article Oncology

Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution

Juan Pablo Alderuccio et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Article Hematology

Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients

Akiko Miyagi Maeshima et al.

BRITISH JOURNAL OF HAEMATOLOGY (2016)

Add to Collection

Article Oncology

Histologic transformation in marginal zone lymphomas

A. Conconi et al.

ANNALS OF ONCOLOGY (2015)

Add to Collection

Article Hematology

Survival of patients with transformed lymphoma in the rituximab era

Hany R. Guirguis et al.

ANNALS OF HEMATOLOGY (2014)

Add to Collection

Article Oncology

Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma

A. H. Meyer et al.

ANNALS OF ONCOLOGY (2014)

Add to Collection

Article Hematology

Incidence, risk factors and outcome of histological transformation in follicular lymphoma

Annarita Conconi et al.

BRITISH JOURNAL OF HAEMATOLOGY (2012)

Add to Collection

Article Medicine, General & Internal

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

B Coiffier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.